1. Home
  2. POWL vs CRSP Comparison

POWL vs CRSP Comparison

Compare POWL & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POWL
  • CRSP
  • Stock Information
  • Founded
  • POWL 1947
  • CRSP 2013
  • Country
  • POWL United States
  • CRSP Switzerland
  • Employees
  • POWL N/A
  • CRSP N/A
  • Industry
  • POWL Electrical Products
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • POWL Energy
  • CRSP Health Care
  • Exchange
  • POWL Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • POWL 2.6B
  • CRSP 3.4B
  • IPO Year
  • POWL N/A
  • CRSP 2016
  • Fundamental
  • Price
  • POWL $167.05
  • CRSP $42.15
  • Analyst Decision
  • POWL Strong Buy
  • CRSP Buy
  • Analyst Count
  • POWL 1
  • CRSP 20
  • Target Price
  • POWL $312.00
  • CRSP $75.72
  • AVG Volume (30 Days)
  • POWL 548.7K
  • CRSP 2.7M
  • Earning Date
  • POWL 04-29-2025
  • CRSP 02-11-2025
  • Dividend Yield
  • POWL 0.65%
  • CRSP N/A
  • EPS Growth
  • POWL 106.54
  • CRSP N/A
  • EPS
  • POWL 13.17
  • CRSP N/A
  • Revenue
  • POWL $1,059,770,000.00
  • CRSP $37,314,000.00
  • Revenue This Year
  • POWL $13.99
  • CRSP $49.76
  • Revenue Next Year
  • POWL $3.99
  • CRSP $257.28
  • P/E Ratio
  • POWL $12.72
  • CRSP N/A
  • Revenue Growth
  • POWL 38.27
  • CRSP N/A
  • 52 Week Low
  • POWL $122.00
  • CRSP $36.52
  • 52 Week High
  • POWL $364.98
  • CRSP $76.86
  • Technical
  • Relative Strength Index (RSI)
  • POWL 37.68
  • CRSP 50.49
  • Support Level
  • POWL $150.46
  • CRSP $40.82
  • Resistance Level
  • POWL $174.29
  • CRSP $46.07
  • Average True Range (ATR)
  • POWL 10.80
  • CRSP 2.57
  • MACD
  • POWL 2.29
  • CRSP -0.27
  • Stochastic Oscillator
  • POWL 57.37
  • CRSP 51.40

About POWL Powell Industries Inc.

Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: